Andrea Monroy Gonzalez

Dr. Andrea Monroy Gonzalez

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 September 2018 in The International Journal of Cardiovascular Imaging
Verified
Journal Article
Open access
PDF file
AGAndrea Monroy Gonzalez
Andrea Monroy Gonzalez
EAErick Alexanderson-Rosas
Erick Alexanderson-Rosas
NPNiek Prakken
Niek Prakken
Luis Eduardo Juarez-OrozcoLuis Eduardo Juarez-Orozco
Luis Eduardo Juarez-Orozco
LWLourdes Walls-Laguarda
Lourdes Walls-Laguarda
RTRene A. Tio
Rene A. Tio
Myocardial Bridging (MB) refers to the band of myocardium that abnormally overlies a segment of a coronary artery. This paper quantitatively evaluates the influence of MB of the left anterior descending artery (LAD) on myocardial perfusion of the entire left ventricle. We studied 131 consecutive patients who underwent hybrid rest/stress 13N-ammonia positron emission tomography (PET) and coronary computed tomography angiography (CCTA) due to suspected myocardial ischemia. Patients with previous myocardial infarction and/or significant coronary artery disease (≥ 50% stenosis) were excluded. Myocardial perfusion measurements were compared between patients with and without LAD-MB. Additionally, we evaluated the relationship between anatomical characteristics (length and depth) of LAD-MB and myocardial perfusion measurements. 17 (13%) patients presented a single LAD-MB. Global myocardial perfusion reserve (MPR) was lower in patients with LAD-MB than in patients without LAD-MB (1.9 ± 0.5 vs. 2.3 ± 0.6, p < 0.01). Global stress myocardial blood flow (MBF) was similar in patients with and without LAD-MB (2.2 ± 0.4 vs. 2.3 ± 0.7 ml/g/min, p = 0.40). Global rest MBF was higher in patients with LAD-MB than in patients without LAD-MB (1.2 ± 0.3 vs. 1.0 ± 0.2 ml/g/min, p < 0.01). Global rest MBF, stress MBF, and MPR quantifications were similar in patients with superficial and deep LAD-MB (all p = NS). We did not find any correlation between length and global rest MBF, stress MBF nor MPR (r = − 0.14, p = 0.59; r = 0.44, p = 0.07; and r = 0.45, p = 0.07 respectively). Quantitative myocardial perfusion suggests that LAD-MB may be related to impaired perfusion reserve, an indicator of microvascular dysfunction. Anatomical characteristics of LAD-MB were not related to changes in myocardial perfusion.

4 October 2018 in Journal of Nuclear Cardiology
Verified
Journal Article
Open access
PDF file
AGAndrea Monroy Gonzalez
Andrea Monroy Gonzalez
RTR. A. Tio
R. A. Tio
JGJ. C. de Groot
J. C. de Groot
HBH. H. Boersma
H. H. Boersma
NPNiek Prakken
Niek Prakken
RSR. H. J. A. Slart
R. H. J. A. Slart
Background Patients with chest pain and no obstructive coronary artery disease have shown a high incidence of major adverse cardiovascular events (MACE). We evaluated the role of absolute myocardial perfusion quantification in predicting all-cause mortality and MACE during long-term follow-up in this group of patients. Methods We studied 79 patients who underwent Nitrogen-13 ammonia PET for quantification of global myocardial blood flow (MBF) and myocardial flow reserve (MFR) due to suspected impaired myocardial perfusion. Patients with coronary artery disease (i.e., > 30% stenosis in one or more coronary arteries) were excluded. We assessed all-cause mortality and MACE. MACE was defined as the composite incidence of death, myocardial infarction (MI), or hospitalization due to heart failure. Results Median follow-up was 8 (IQR: 3-14) years. Univariate Cox regression showed that only MFR (P = 0.01) was a predictor of all-cause mortality. Univariate Cox regression analysis showed that both MFR and Stress MBF were predictors of the composite endpoint of MACE (P < 0.001 and P = 0.01, respectively). Conclusion Quantitative assessment of myocardial perfusion may predict all-cause mortality and MACE in patients with chest pain and normal coronary arteries in the long-term follow-up.

4 March 2019 in Journal of Nuclear Cardiology
Verified
Journal Article
Open access
PDF file
Luis Eduardo Juarez-OrozcoLuis Eduardo Juarez-Orozco
Luis Eduardo Juarez-Orozco
AGAndrea Monroy Gonzalez
Andrea Monroy Gonzalez
NPNiek Prakken
Niek Prakken
WNWalter Noordzij
Walter Noordzij
JKJuhani Knuuti
Juhani Knuuti
Riemer H.J.A. SlartRiemer H.J.A. Slart
Riemer H.J.A. Slart
Noninvasive imaging modalities offer the possibility to dynamically evaluate cardiac motion during the cardiac cycle by means of ECG-gated acquisitions. Such motion characterization along with orientation, segmentation preprocessing, and ultimately, phase analysis, can provide quantitative estimates of ventricular mechanical synchrony. Current evidence on the role of mechanical synchrony evaluation is mainly available for echocardiography and gated single-photon emission computed tomography, but less is known about the utilization of gated positron emission tomography (PET). Although data available are sparse, there is indication that mechanical synchrony evaluation can be of diagnostic and prognostic values in patients with known or suspected coronary artery disease-related myocardial ischemia, prediction of response to cardiac resynchronization therapy, and estimation of risk for adverse cardiac events in patients’ heart failure. As such, the evaluation of mechanical ventricular synchrony through phase analysis of gated acquisitions represents a value addition to modern cardiac PET imaging modality, which warrants further research and development in the evaluation of patients with cardiovascular disease.

22 March 2019 in Journal of Nuclear Cardiology
Verified
Journal Article
Open access
PDF file
AGAndrea Monroy Gonzalez
Andrea Monroy Gonzalez
Luis Eduardo Juarez-OrozcoLuis Eduardo Juarez-Orozco
Luis Eduardo Juarez-Orozco
CHChunlei Han
Chunlei Han
IVIssi R. Vedder
Issi R. Vedder
David Vállez GarcíaDavid Vállez García
David Vállez García
EAErick Alexanderson-Rosas
Erick Alexanderson-Rosas
We explored agreement in the quantification of myocardial perfusion by cross-comparison of implemented software packages (SPs) in three distinguishable patient profile populations.

9 August 2016 in Journal of Nuclear Cardiology
Verified
Journal Article
Closed access
PDF file
EAE. Alexanderson-Rosas
E. Alexanderson-Rosas
AGAndrea Monroy Gonzalez
Andrea Monroy Gonzalez
Luis Eduardo Juarez-OrozcoLuis Eduardo Juarez-Orozco
Luis Eduardo Juarez-Orozco
MMM. M. Martinez-Aguilar
M. M. Martinez-Aguilar
EEE. Estrada
E. Estrada
MSMaría Elena Soto
María Elena Soto

24 December 2022 in Journal of Nuclear Cardiology
Verified
Journal Article
Open access
PDF file
AGAndrea Monroy Gonzalez
Andrea Monroy Gonzalez
PEPaola A. Erba
Paola A. Erba
Riemer H.J.A. SlartRiemer H.J.A. Slart
Riemer H.J.A. Slart